Bait Vegag Real Estate Development Ltd (TLV:BVGG)

Theseus Pharmaceuticals Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	134.26	141.44	131.04	271.89	298.54	121.47
Revenue Growth (YoY)	10.59%	7.94%	-51.80%	-8.93%	145.77%	15.07%
Cost of Revenue	108	113.94	110.17	215.06	240.38	104.53
Gross Profit	26.26	27.5	20.87	56.83	58.16	16.95
Selling, General & Admin	31.12	29.93	28.71	29.57	21.02	15.39
Other Operating Expenses	0.71	0.79	0.71	1.33	0.32	-0.01
Operating Expenses	31.83	30.72	29.41	35.56	21.34	15.38
Operating Income	-5.57	-3.22	-8.54	21.27	36.83	1.57
Interest Expense	-2.21	-1.09	-	-0	-0.25	-0.23
Interest & Investment Income	5.12	4.9	6.39	0.9	0	0.04
Other Non Operating Income (Expenses)	-3.76	-3.76	-4.82	-7.75	-5.63	-3.55
EBT Excluding Unusual Items	-6.41	-3.18	-6.97	14.43	30.95	-2.17
Asset Writedown	-	-	-	-	-	-0.78
Pretax Income	-6.41	-3.18	-6.97	14.43	30.95	-2.95
Income Tax Expense	-1.05	-0.25	-0.64	4.23	-	-
Earnings From Continuing Operations	-5.36	-2.93	-6.33	10.2	30.95	-2.95
Minority Interest in Earnings	-0.02	-0.03	-0.02	-0.27	-30.95	2.95
Net Income	-5.38	-2.96	-6.35	9.93	-	-
Net Income to Common	-5.38	-2.96	-6.35	9.93	-	-
Shares Outstanding (Basic)	56	55	55	55	55	57
Shares Outstanding (Diluted)	56	55	55	55	55	57
Shares Change (YoY)	-1.80%	-	-	-	-3.46%	-
EPS (Basic)	-0.10	-0.05	-0.12	0.18	-	-
EPS (Diluted)	-0.10	-0.05	-0.12	0.18	-	-
Free Cash Flow	-130.23	-130.96	-107.7	-4.78	155.05	-0.3
Free Cash Flow Per Share	-2.33	-2.38	-1.96	-0.09	2.82	-0.01
Gross Margin	19.56%	19.44%	15.93%	20.90%	19.48%	13.95%
Operating Margin	-4.15%	-2.28%	-6.52%	7.82%	12.34%	1.29%
Profit Margin	-4.00%	-2.09%	-4.85%	3.65%	-	-
Free Cash Flow Margin	-97.00%	-92.59%	-82.19%	-1.76%	51.94%	-0.25%
EBITDA	-5.3	-2.97	-8.35	21.41	36.94	1.69
EBITDA Margin	-3.94%	-2.10%	-6.37%	7.87%	12.37%	1.39%
D&A For EBITDA	0.28	0.26	0.19	0.14	0.11	0.13
EBIT	-5.57	-3.22	-8.54	21.27	36.83	1.57
EBIT Margin	-4.15%	-2.28%	-6.52%	7.82%	12.34%	1.29%
Effective Tax Rate	-	-	-	29.31%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.